BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
Copyright: ©Author(s) 2026.
World J Hepatol. Jun 27, 2026; 18(6): 118905
Published online Jun 27, 2026. doi: 10.4254/wjh.118905
Table 1 Baseline characteristics of the total cohort and subgroups with and without infection, n (%)/mean ± SD/median (interquartile range)
VariableCategory
Total (n = 182)Infection
+ (n = 39)- (n = 143)
Age (years)67.84 ± 11.7269.85 ± 10.6867.29 ± 11.97
SexMale102 (56.0)26 (66.7)76 (53.1)
Female80 (44.0)13 (33.3)67 (46.9)
ASA-PS
02 (1.1)02
110 (5.5)19
2157 (86.3)35122
313 (7.1)310
Chronic kidney diseasePresence24 (13.2)3 (7.7)21 (14.7)
Diabetes mellitusPresence48 (26.4)13 (33.3)35 (24.5
Habitual smokingYes54 (29.7)14 (35.940 (28.0)
Habitual alcohol Yes55 (30.2)10 (25.6)45 (31.5)
Malignant statusMalignant170 (93.4)38 (97.4)132 (92.3)
Metastatic liver tumors87 (47.8)21 (53.8)66 (46.2)
HCC63 (34.6)13 (33.3)50 (35.0)
CCC15 (8.2)3 (7.7)12 (8.4)
Others5 (2.7)1 (2.6)4 (2.8)
Benign12 (6.6)1 (2.6)11 (7.7)
Child-PughA178 (97.8)38 (97.4)140 (97.9)
B4 (2.2)1 (2.6)3 (2.1)
ICG R1510.0 (8.00-15.00)10.0 (8.0-15.0)10.0 (8.0-13.0)
Body mass index (kg/m2)22.62 (20.37-24.86)23.44 (20.24-24.53)22.52 (20.48-25.02)
Albumin (g/dL)4.05 (3.80-4.30)4.00 (3.70-4.30)4.10 (3.80-4.30)
Albumin (g/dL)< 3.518 (9.9)7 (17.9)11 (7.7)
≥ 3.5164 (90.1)32 (82.1)132 (92.3)
PNI47.00 (44.12-50.50)48.0 (44.75-50.50)47.0 (44.00-50.50)
PNI< 4553 (29.1)10 (25.6)43 (30.1)
≥ 45129 (70.9)29 (74.4)100 (69.9)
Zn (μg/dL)72.00 (63.00-80.10)65.2 (57.05-76.25)72.00 (63.00-80.10)
Zn (μg/dL)< 80 132 (72.5)34 (87.2)98 (68.5)
≥ 80 50 (27.5)5 (12.8)45 (31.5)
CONUT score2.00 (1.00-2.00)1.00 (0.00-6.00)2.00 (0.00-6.00)
CONUT score0-190 (49.5)22 (56.4)68 (47.6)
≥ 292 (50.5)17 (43.6)75 (52.4)
MIH approachLaparoscopic 87 (47.8)16 (41.0)71 (49.7)
Robotic95 (52.2)23 (59.0)72 (50.3)
Operative procedureAnatomical resection115 (63.2)27 (69.2)88 (61.5)
Partial resection67 (36.8)12 (30.8)55 (38.5)
Iwate criteria6.00 (5.00-8.00)7.00 (2.00-11.00)6.00 (1.00-11.00)
Operative time (hour)6.45 (4.50-7.97)6.85 (5.50-8.52)6.13 (4.28, 7.88)
Estimated blood loss (mL)120.5 (61.3-284.5)178.0 (83.0-445.5)106.0 (55.00-261.5)
Table 2 Results of univariable and multivariable logistic regression analyses for postoperative infection
Variable (reference)Category or unitUnivariable logistic model
Multivariable logistic model
OR (95%CI)
P value
OR (95%CI)
P value
Age (year)1 1.02 (0.99-1.06)0.228
Sex (female)Male1.76 (0.84-3.70)0.148
ASA-PS (0-1)2-33.17 (0.396-25.3)0.277
Chronic kidney diseasePresence0.48 (0.14-1.72)0.300
Diabetes mellitusPresence1.54 (0.72-3.32)0.306
Habitual smokingYes1.44 (0.68-3.05)0.332
Habitual alcohol consumptionYes0.75 (0.34-1.67)0.558
Malignant status (benign)Malignant3.19 (0.40-25.50)0.467
Child-Pugh (B)A1.23 (0.12-12.1)> 0.999
ICG R15 (point)1 0.99 (0.94-1.04)0.574
Body mass index (kg/m2)11.03 (0.95-1.12)0.572
Albumin (g/dL)1 0.47 (0.18-1.21)0.115
Albumin (≥ 3.5 g/dL)< 3.5 2.62 (0.94-7.30)0.0712.28 (0.79-6.57)0.126
PNI (point)1 1.00 (0.92-1.07)0.898
PNI (≥ 45 points)< 45 0.80 (0.36-1.79)0.693
Zn (μg/dL)1 0.96 (0.94-0.99)0.0150.96 (0.94-0.99)0.009
Zn (≥ 80 μg/dL)< 80 0.32 (0.12-0.87)0.0250.32 (0.11-0.90)0.032
CONUT score (point)1 0.96 (0.74-1.25)0.455
CONUT score (≥ 2 points)0-1 0.70 (0.34-1.43)0.369
MIH approach (robot)Lap1.42 (0.69-2.90)0.370
Operative procedure (partial)Anatomical0.71 (0.33-1.52)0.455
Iwate criteria (point)1 1.05 (0.91-1.21)0.497
Operative time (hour)1 1.17 (1.00-1.37)0.0431.12 (0.93-1.34)0.228
Estimated blood loss (mL)1001.09 (1.00-1.19)0.0391.08 (0.98-1.20)0.140
Table 3 Results of univariable and multivariable logistic regression analyses comparing Clavien–Dindo grade IIIa–negative and grade IIIa–positive groups
VariableCategory or unitUnivariable logistic model
Multivariable logistic model
OR (95%CI)
P value
OR (95%CI)
P value
Age (year)11.05 (0.97-1.14)0.190
Sex (female)Male0.98 (0.25-3.77)0.976
ASA-PS (0-1)2-31.85 (0.21-16.13)0.581
Chronic kidney diseasePresence0.82 (0.10-6.82)0.850
Diabetes mellitusPresence0.79 (0.16-3.93)0.772
Habitual smokingYes1.97 (0.51-7.63)0.328
Habitual alcohol consumptionYes1.16 (0.28-4.83)0.835
Malignant status (benign)Malignant1.48 (0.17-194.84)10.7801
Child-Pugh (B)A0.141(0.013-1.52)0.106
ICG R15 (point)1 0.96 (0.84-1.10)0.559
Body mass index (kg/m2)1 0.77 (0.61-0.97)0.0290.79 (0.61-1.02)0.066
Albumin (g/dL)1 0.15 (0.02-0.91)0.0390.54 (0.07-4.19)0.558
Albumin (≥ 3.5 g/dL)< 3.5 3.15 (0.58-17.00)0.183
PNI (point)1 0.98 (0.85-1.13)0.752
PNI (≥ 45 points)< 45 0.68 (0.14-3.40)0.642
Zn (μg/dL)1 0.93 (0.88-0.98)0.0070.94 (0.88-1.00)0.046
Zn (≥ 80 μg/dL)< 80 7.77 (0.95-1008.52)10.0571
CONUT score (point)1 0.62 (0.33-1.17)0.139
CONUT score (≥ 2 points)0-1 0.26 (0.05-1.30)0.102
MIH approach (robot)Lap3.38 (0.68-16.70)0.136
Operative procedure (partial)Anatomical0.48 (0.10-2.35)0.362
Iwate criteria (point)1 1.33 (0.98-1.81)0.070
Operative time (minute)11.55 (1.13-2.13)0.0061.58 (1.09-2.30)0.016
Estimated blood loss (mL)100 1.06 (0.92-1.21)0.429
Table 4 Preoperative serum zinc level-specific infection rates, n (%)
Serum zinc level (μg/dL)
Number of
patients
Number of infected patients
< 603211 (34.4)
60 to < 704611 (23.9)
70 to < 805412 (22.2)
≥ 80505 (10.0)
Table 5 Comparison of baseline characteristics according to preoperative serum zinc level, n (%)/median (interquartile range)
VariableCategoryPreoperative serum zinc level
P value
< 80 μg/dL (n = 132)
≥ 80 μg/dL (n = 50)
Age (years)69.61 (10.96)63.16 (12.46)0.001
SexMale73 (55.3)29 (58.0)0.867
Female59 (44.7)21 (42.0)
ASA-PS01 (0.8)1 (2.0)0.212
16 (4.5)4 (8.0)
2113 (85.6)44 (88.0)
312 (9.1)1 (2.0)
Chronic kidney diseasePresence19 (14.4)5 (10.0)0.624
Diabetes mellitusPresence35 (26.5)13 (26.0)> 0.999
Habitual smokingYes40 (30.3)14 (28.0)0.857
Habitual alcohol Yes40 (30.3)15 (30.0)> 0.999
Malignant statusMalignant128(96.9)42 (84.0)0.004
Benign4 (3.1)8 (16.0)
Child-PughA129 (97.7)49 (98.0)> 0.999
B3 (2.3)1 (2.0)
ICG R1511.0 (8.0-15.0)10.0 (7.3-12.8)0.094
Body mass index (kg/m2)23.1 (4.2)23.1 (3.9)0.964
Albumin (g/dL)3.99 (0.37)4.20 (0.36)0.001
Albumin (g/dL)< 3.517 (12.9)1 (2.0)0.027
≥ 3.5115 (87.1)49 (98.0)
PNI46.80 (4.55)48.87 (4.63)0.007
PNI< 4542 (31.8)11 (22.0)0.207
≥ 4590 (68.2)39 (78.0)
CONUT score2.0 (0.0-6.0)1.0 (0.0-5.0)0.428
CONUT score0-163 (47.7)27 (54.0)0.508
≥ 269 (52.3)23 (46.0)
MIH approachLap62 (47.0)25 (50.0)0.742
Robot70 (53.0)25 (50.0)
Operative procedureAnatomical83 (62.9)32 (64.0)1.000
Partial49 (37.1)18 (36.0)
Iwate criteria6.0 (1.0-11.0)6.5 (2.0-11.0)0.683
Operative time (minute)6.48 (4.55-7.90)6.16 (4.17-8.36)0.928
Estimated blood loss (mL)128 (2.0-2520)94 (3.0-1544)0.304


Write to the Help Desk